[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  overnightstocks.com [@overnight_stock](/creator/twitter/overnight_stock) on x XXX followers Created: 2025-07-23 09:46:36 UTC $TLX Telix Stock Slumps on SEC Probe Despite Strong Q2 | via • Shares down as much as XX% after Telix disclosed SEC subpoena tied to disclosures on prostate cancer drugs. • Q2 revenue surged 63%, with 2025 guidance reaffirmed at $770M–$800M. • Jefferies trimmed PT slightly from A$34.50 to A$34.00, citing lengthy regulatory process. • Shares -XXXX% pre-market. XXX engagements  **Related Topics** [$800m](/topic/$800m) [$770m](/topic/$770m) [drugs](/topic/drugs) [stocks](/topic/stocks) [q2](/topic/q2) [sec](/topic/sec) [$tlx](/topic/$tlx) [Post Link](https://x.com/overnight_stock/status/1947956505908584945)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
overnightstocks.com @overnight_stock on x XXX followers
Created: 2025-07-23 09:46:36 UTC
$TLX Telix Stock Slumps on SEC Probe Despite Strong Q2 | via
• Shares down as much as XX% after Telix disclosed SEC subpoena tied to disclosures on prostate cancer drugs. • Q2 revenue surged 63%, with 2025 guidance reaffirmed at $770M–$800M. • Jefferies trimmed PT slightly from A$34.50 to A$34.00, citing lengthy regulatory process. • Shares -XXXX% pre-market.
XXX engagements
/post/tweet::1947956505908584945